Ebbs, A <br/><br/>
Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration.  [electronic resource] 

 -  Transplantation proceedings  Aug 2002 
 - 1378-81 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(02)02894-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cyclosporine--therapeutic use<br/>Drug Therapy, Combination<br/>Graft Rejection--prevention & control<br/>Granzymes<br/>Heart Transplantation--immunology<br/>Immunosuppressive Agents--therapeutic use<br/>Interleukin-10--antagonists & inhibitors<br/>Membrane Glycoproteins--analysis<br/>Perforin<br/>Pore Forming Cytotoxic Proteins<br/>Rats<br/>Rats, Inbred BN<br/>Rats, Inbred Lew<br/>Serine Endopeptidases--analysis<br/>Tacrolimus--therapeutic use<br/>Transplantation, Homologous--immunology<br/>Transplantation, Isogeneic--immunology